The purpose of this study was to investigate the effects of soybean phospholipid, as a steric
stabilizer, on improving dissolution rate, storage stability and bioavailability of ginkgolides …

Deferasirox (DFX) is an oral iron‐chelating agent and classified into class II of the
Biopharmaceutics Classification System. Low bioavailability of the drug due to insufficient …

The objectives of this study are the development and evaluation of modified release multi-
particulate drug delivery systems containing a BCS class II drug (meloxicam), formulated as …

The objective of this work was to study the coating process of diclofenac sodium pellets, with
the commercial aqueous coating suspension for enteric release–Acryl-Eze® MP, in a fluid …

The present work aims at studying process parameters affecting coating of minitablets (3 mm
in diameter) through Wurster coating process. Minitablets of Naproxen with high drug …

Objective: The objective of this study is to investigate the wet-milled-drug layering process
which could significantly improve the dissolution rate and oral bioavailability of fenofibrate …

Over the years, excipients have undergone a paradigm shift from being “inert ingredients” to
“functional ingredients” in a dosage form. Excipients are being increasingly used to enhance …

In this work, diclofenac sodium pellets were produced through an extrusion/spheronization
process and subsequently coated in a fluidized bed coater column with a Wurster insert. The …

Layered and coated pellets were formulated to control the release of the diclofenac sodium
selected as model drug. A highly water soluble isomalt inert pellet core material was used to …

The process for developing drug delivery systems has evolved over the past two decades
with more scientific rigor, involving a collaboration of various fields, ie, biology, chemistry …